P&G stops selling Vicks Action 500 Extra after ban on fixed drug combination

Spread the love

March 15: US consumer health giant Procter & Gamble’s India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.

The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by the health ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care Ltd informed the stock exchange.

The drug was one of 344 drug combinations including several antibiotics and analgesics that India ordered to be prohibited saying a government-appointed panel of experts had found the combinations lacked “therapeutic justification.”

P&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.

It wasn’t immediately clear how much the product contributed to P&G’s sales.

At 1043 hours, the company’s stock was trading at Rs 6,039.25, down Rs 89 or 1.45% from previous day’s close.

Recommended For You

About the Author: Editorjknews

Facebook